Mednet Reports

The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.

MEDICAL FRONTIERS - European Respiratory Society (ERS) Annual Congress 2013

New Treatment Options in Pulmonary Arterial Hypertension Appear to Move Treatment Goals Beyond Symptom Control

Barcelona, Spain / September 7-11, 2013

Barcelona - New data presented at the ERS 2013 from trials published just weeks before the meeting was convened, document a paradigm shift in the treatment of pulmonary hypertension. In pulmonary arterial hypertension, the benefit of a new...

PRIORITY PRESS - 35th Annual Congress of the European Society of Cardiology (ESC)

Phase III Trials in Pulmonary Arterial Hypertension Focus on Clinical Events Rather Than Symptom Control

Amsterdam, Netherlands / August 31-September 4, 2013

Amsterdam - In pulmonary arterial hypertension (PAH), trials are being increasingly designed to evaluate protection against disease progression rather than symptom control alone, according to data presented at the 2013 ESC. The trial data...

PRIORITY PRESS - 35th Annual Congress of the European Society of Cardiology (ESC)

Vascular Outcomes Trials Confirm Safety of DPP-4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus

Amsterdam, Netherlands / August 31-September 4, 2013

Amsterdam - Both of the first two trials in a series to confirm the cardiovascular safety of dipeptidyl peptidase-4 (DPP-4) inhibitors met their primary end point. Although there are important differences in the design and information...

MEDI-NEWS - Based on Lancet 2013;381(9869):825-35.

Invasive Meningococcal Disease in Infants: Immunogenicity and Safety of a Novel Multi-Component Serogroup B Vaccine

Serogroup B is now the dominant cause of invasive meningococcal disease (IMD) in Canada where it disproportionally affects infants. This underscores the importance of having an effective vaccine for this vulnerable age group. A...

PRIORITY PRESS - 8th World Congress of Melanoma

New Advances in the Treatment of Basal Cell Carcinoma: Targeting the Hedgehog Signaling Pathway

Hamburg, Germany / July 17-20, 2013

Hamburg - Until recently, treatment options for advanced basal cell carcinoma (BCC) were limited and suboptimal. Research into novel therapeutic targets identified mutations in the hedgehog signaling pathway as a possible cause of new...

PRIORITY PRESS - XXIV Congress of the International Society on Thrombosis and Haemostasis (ISTH)/ 59th Annual Scientific and Standardization Committee (SSC) Meeting

Potential for Advances in the Treatment of Hemophilia A

Amsterdam, The Netherlands / June 29-July 4, 2013

Amsterdam - Current treatment for patients with hemophilia A, the most common hereditary coagulation disorder, involves intravenous injection of human factor VIII given on demand in response to a bleeding event or as a prophylactic therapy....

MEDICAL FRONTIERS - XXIV Congress of the International Society of Thrombosis and Haemostasis (ISTH)/ 59th Annual SSC Meeting

New Horizons in the Treatment of Hemophilia A and B

Amsterdam, The Netherlands / June 29–July 4, 2013

Amsterdam - Current treatment for patients with hemophilia involves intravenous injection of clotting factor concentrate either given on demand in response to a bleeding event or as prophylactic therapy. Since the introduction of...

ABSTRACTS in PERSPECTIVE - Based on presentations from the 73rd Scientific Sessions of the American Diabetes Association (ADA)

Maturing Clinical Experience with SGLT2 Inhibitors Is Clarifying Clinical Applications

Chicago, Illinois / June 21-25, 2013

EDITORIAL OVERVIEW: Philip A. McFarlane, MD, PhD, FRCPC Division of NephrologySt. Michael’s HospitalUniversity of TorontoToronto, Ontario Jean-Francois Yale, MD, FRCPCMcGill University Health CentreMcGill UniversityMontreal,...

PRIORITY PRESS - 73rd Scientific Sessions of the American Diabetes Association (ADA)

Clarity Grows on the Role of SGLT2 Inhibitors in Routine Control of Type 2 Diabetes

Chicago, Illinois / June 21-25, 2013

Chicago - The order in which oral agents are employed to control type 2 diabetes mellitus (T2DM) is under consideration as a result of the introduction of sodium glucose co-transporter 2 (SGLT2) inhibitors, based on clinical trial results...

PRIORITY PRESS - 73rd Scientific Sessions of the American Diabetes Association (ADA)

New Antidiabetic Medications Yield Flatter PK, More Predictable Blood Glucose Levels than Standards

Chicago, Illinois / June 21-25, 2013

Chicago - New therapeutic options for insulin-dependent diabetes are inching closer to the ideal of predictable blood glucose control over each 24-hour dosing period, according to large trial data presented at the ADA. Relative to the...

PAGE 9 OF 108   1 2 3 4 5 6 7 8 9 10 ...